Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueGross ProfitLeasesOther Gross PP&E AdjustmentsReceivables - NetShares Outstanding
Ratios

Guided Therapeutics (GTHP) Revenue (Gross) (2023 - 2024)

Historic Revenue (Gross) for Guided Therapeutics (GTHP) over the last 2 years, with Q1 2024 value amounting to $3000.0.

  • Guided Therapeutics' Revenue (Gross) changed N/A to $3000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $3000.0, marking a year-over-year decrease of 5000.0%. This contributed to the annual value of $3000.0 for FY2024, which is 5000.0% down from last year.
  • According to the latest figures from Q1 2024, Guided Therapeutics' Revenue (Gross) is $3000.0.
  • Guided Therapeutics' Revenue (Gross)'s 5-year high stood at $6000.0 during Q4 2023, with a 5-year trough of $3000.0 in Q1 2024.